Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment (Q62818047)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment |
clinical trial |
Statements
Evaluating the Interest of GEP-based Derived Histone Acetylation Score to Identify Myeloma Patients Who Could Benefit From Treatment With HDAC Inhibitor (English)
0 references
23 April 2018
0 references
31 December 2018
0 references
30
0 references
18 year
0 references